2024.09.30
MileCell Bio, a distinguished provider of primary hepatocytes, microsomes, hepatocyte media, and related products, is gearing up for a remarkable presence at the AASDL, The Liver Meeting, from November 15th to 19th, 2024, at the San Diego Convention Center in California. Our booth number, Exhibit Hall BC-1833, will be a hub for showcasing our commitment to delivering reliable and relevant research models for ADME and toxicology in drug discovery
.
As we prepare to engage with the hepatology community, we are eager to demonstrate how our products empower informed decision-making throughout the drug development process. Our primary hepatocytes are pivotal for assessing drug metabolism, toxicity, and efficacy, playing a crucial role in preclinical research and clinical studies
.
The Liver Meeting is a congregation of over 9000 professionals, including hepatologists, researchers, and healthcare providers, all dedicated to advancing liver health. Our participation is a testament to our dedication to the field and our mission to provide innovative solutions for liver disease treatment and research
.
We cordially invite all attendees to visit our booth, where our team of experts will be available to discuss our products, share insights, and explore collaborative opportunities. MileCell Bio looks forward to contributing to the scientific dialogue and to the advancement of liver health at this prestigious event.
